Fifth Third Bancorp Baxter International Inc Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Baxter International Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 23,426 shares of BAX stock, worth $770,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,426

Previous 25,667 8.73%

Holding current value

$770,012

Previous $858,000 3.61%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$32.85 - $40.26 $73,616 - $90,222	-2,241 Reduced 8.73%	23,426 $889,000
Q2 2024 Jul 22, 2024	SELL	$32.87 - $43.55 $506,197 - $670,670	-15,400 Reduced 37.5%	25,667 $858,000
Q1 2024 Apr 23, 2024	SELL	$37.88 - $43.77 $118,715 - $137,175	-3,134 Reduced 7.09%	41,067 $1.76 Million
Q4 2023 Jan 19, 2024	SELL	$31.71 - $38.95 $239,410 - $294,072	-7,550 Reduced 14.59%	44,201 $1.71 Million
Q3 2023 Oct 31, 2023	BUY	$37.32 - $49.29 $719,604 - $950,409	19,282 Added 59.39%	51,751 $1.95 Million
Q2 2023 Jul 25, 2023	BUY	$39.98 - $47.68 $100,669 - $120,058	2,518 Added 8.41%	32,469 $1.48 Million
Q1 2023 Apr 24, 2023	SELL	$37.58 - $52.57 $727,248 - $1.02 Million	-19,352 Reduced 39.25%	29,951 $1.21 Million
Q4 2022 Jan 25, 2023	SELL	$49.7 - $57.71 $2.86 Million - $3.32 Million	-57,579 Reduced 53.87%	49,303 $0
Q3 2022 Oct 25, 2022	SELL	$53.86 - $66.8 $270,754 - $335,803	-5,027 Reduced 4.49%	106,882 $5.76 Million
Q2 2022 Aug 04, 2022	SELL	$63.83 - $80.0 $670,087 - $839,840	-10,498 Reduced 8.58%	111,909 $7.19 Million
Q1 2022 Apr 19, 2022	SELL	$76.85 - $89.45 $24,284 - $28,266	-316 Reduced 0.26%	122,407 $9.49 Million
Q4 2021 Feb 01, 2022	BUY	$74.57 - $87.19 $245,708 - $287,291	3,295 Added 2.76%	122,723 $10.5 Million
Q3 2021 Oct 15, 2021	BUY	$73.77 - $83.61 $77,974 - $88,375	1,057 Added 0.89%	119,428 $9.61 Million
Q2 2021 Aug 06, 2021	SELL	$80.5 - $88.01 $104,730 - $114,501	-1,301 Reduced 1.09%	118,371 $9.53 Million
Q1 2021 May 07, 2021	SELL	$76.38 - $86.03 $2,444 - $2,752	-32 Reduced 0.03%	119,672 $10.1 Million
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $235,367 - $257,127	3,122 Added 2.68%	119,704 $9.61 Million
Q3 2020 Nov 09, 2020	BUY	$78.33 - $90.73 $126,737 - $146,801	1,618 Added 1.41%	116,582 $9.38 Million
Q2 2020 Aug 05, 2020	SELL	$78.66 - $94.14 $40,431 - $48,387	-514 Reduced 0.45%	114,964 $9.9 Million
Q1 2020 May 05, 2020	SELL	$71.57 - $93.3 $375,384 - $489,358	-5,245 Reduced 4.34%	115,478 $9.38 Million
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $87,591 - $101,009	1,142 Added 0.96%	120,723 $10.1 Million
Q3 2019 Nov 14, 2019	BUY	$81.4 - $89.78 $53,072 - $58,536	652 Added 0.55%	119,581 $10.5 Million
Q2 2019 Aug 07, 2019	BUY	$73.44 - $82.41 $203,796 - $228,687	2,775 Added 2.39%	118,929 $9.74 Million
Q1 2019 May 14, 2019	SELL	$64.48 - $81.31 $94,656 - $119,363	-1,468 Reduced 1.25%	116,154 $9.44 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $2.22 Million - $2.81 Million	-36,123 Reduced 23.5%	117,622 $7.74 Million
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $10.3 Million - $11.3 Million	-145,695 Reduced 48.66%	153,745 $11.9 Million
Q2 2018 Aug 14, 2018	BUY	$63.43 - $75.41 $661,701 - $786,677	10,432 Added 3.61%	299,440 $22.1 Million
Q1 2018 May 15, 2018	BUY	$62.56 - $72.26 $2.21 Million - $2.55 Million	35,296 Added 13.91%	289,008 $18.8 Million
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $181,646 - $195,243	-2,956 Reduced 1.15%	253,712 $16.4 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $361,700 - $392,764	6,079 Added 2.43%	256,668 $16.1 Million
Q2 2017 Aug 11, 2017	BUY	N/A	250,589	250,589 $15.2 Million

Others Institutions Holding BAX

# of Institutions

1,008

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Baxter International Inc Transaction History